A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 20, 2016 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: Starting Year 20! Allen Loyd V Jr	Jan/Feb 2016 Pg. 4
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Choo Winnie	Jan/Feb 2016 Pg. 6-10
Microbial Identification in Pharmaceutical Compounding Hyde Tiffany, Anstead James, Schade Lisa, Zellner James	Jan/Feb 2016 Pg. 13-18
Basic Principles of Lyophilization, Part 2 Akers Michael J	Jan/Feb 2016 Pg. 20-27
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Pritchett Jon, Mixon William, O'Connell Kevin	Jan/Feb 2016 Pg. 29-36
Formulation and Stability of Solutions Akers Michael J	Jan/Feb 2016 Pg. 41-45
Calculations Stockton Shelly J	Jan/Feb 2016 Pg. 46
Aprepitant 80-mg Capsules Allen Loyd V Jr	Jan/Feb 2016 Pg. 48
Aripiprazole 10-mg Oral Dissolving Tablets Allen Loyd V Jr	Jan/Feb 2016 Pg. 49
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Allen Loyd V Jr	Jan/Feb 2016 Pg. 50
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Allen Loyd V Jr	Jan/Feb 2016 Pg. 51
Mupirocin Calcium 2% Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 52
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 53
Thrombin 1,000 Units/mL Topical Solution, Sterile Allen Loyd V Jr	Jan/Feb 2016 Pg. 54
Tropicamide 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 55
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 56
Voriconazole 10-mg/mL Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 57
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini	Jan/Feb 2016 Pg. 58-62
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R	Jan/Feb 2016 Pg. 63-70
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B	Jan/Feb 2016 Pg. 71-80
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa	Jan/Feb 2016 Pg. 81-85
PostScription: The Home Field Advantage Cabaleiro Joe	Jan/Feb 2016 Pg. 86-87
PreScription: Compounding: A Changing Paradigm Allen Loyd V Jr	Mar/Apr 2016 Pg. 92
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations McCrory Gary	Mar/Apr 2016 Pg. 95-96
Root Cause Analysis, Part 2: Sterile Compounding Cabaleiro Joe, Jackson Kathleen	Mar/Apr 2016 Pg. 99-104
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo	Mar/Apr 2016 Pg. 114-122
Basics of Compounding: Capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 125-134
Formulation and Stability of Solutions Akers Michael J	Mar/Apr 2016 Pg. 137-141
Calculations Stockton Shelly J	Mar/Apr 2016 Pg. 142
Blue Goo Anti-Itch Gel Allen Loyd V Jr	Mar/Apr 2016 Pg. 144
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 145
Medicated Polyox Bandage for Skin Ulcers Allen Loyd V Jr	Mar/Apr 2016 Pg. 146
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Allen Loyd V Jr	Mar/Apr 2016 Pg. 147
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand	Mar/Apr 2016 Pg. 148-154
Utilization of Compounded Medications in an Oral Medicine Practice Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel	Mar/Apr 2016 Pg. 155-158
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy	Mar/Apr 2016 Pg. 159-163
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Nahata Milap C	Mar/Apr 2016 Pg. 164-166
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
PreScription: Patient Access to Pharmaceuticals Allen Loyd V Jr	May/Jun 2016 Pg. 180
Current Perspectives on the Syringe Delivery System Akers Michael J	May/Jun 2016 Pg. 182-186
Compounding in Nigeria Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick	May/Jun 2016 Pg. 189-192
IACP Names Voliva Executive Vice President McCrory Gary	May/Jun 2016 Pg. 194
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Sturn Kayla M, Collin Michael	May/Jun 2016 Pg. 197-201
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Basics of Compounding: Special Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 209-214
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Akers Michael J	May/Jun 2016 Pg. 217-222
Calculations Stockton Shelly J	May/Jun 2016 Pg. 224
Carboplatin 50-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 226
Cefotetan Disodium Injection Allen Loyd V Jr	May/Jun 2016 Pg. 227
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Allen Loyd V Jr	May/Jun 2016 Pg. 228
Dexpanthenol 5% Nasal Spray Allen Loyd V Jr	May/Jun 2016 Pg. 229
Indomethacin Gel Allen Loyd V Jr	May/Jun 2016 Pg. 230
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	May/Jun 2016 Pg. 231
Montelukast Sodium 5-mg Fast-Dissolving Film Allen Loyd V Jr	May/Jun 2016 Pg. 232
Pain-Away II Headache Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 233
Sodium Nitroprusside 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 234
Zolpidem Tartrate 5-mg and 10-mg Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 235
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C	May/Jun 2016 Pg. 236-238
Topical Metered-dosing Dispenser Performance Evaluation Liu Qiang, Kupiec Thomas C, Vu Nicole T	May/Jun 2016 Pg. 239-246
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C	May/Jun 2016 Pg. 247-249
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob	May/Jun 2016 Pg. 250-256
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S	May/Jun 2016 Pg. 257-261
PostScription: Supporting Your Alma Mater: Whose World Will You Change? Tigelaar Michele	May/Jun 2016 Pg. 262-263
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Allen Loyd V Jr	Jul/Aug 2016 Pg. 268 View Sample
Compounding Transdermal Medication for Feline Patients Eichstadt Lauren R	Jul/Aug 2016 Pg. 271-274
Case Report: Pediatric Scar Management After Open-heart Surgery Phan Ha, Harger Beau, Estrada Nick	Jul/Aug 2016 Pg. 277-280
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Noorian Shaun, Vahedi Navid	Jul/Aug 2016 Pg. 283-292
IACP's 2016 Compounders on Capitol Hill Asks	Jul/Aug 2016 Pg. 294-296
Basics of Compounding: Compounding Films Allen Loyd V Jr	Jul/Aug 2016 Pg. 298-305
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Akers Michael J	Jul/Aug 2016 Pg. 307-314
Calculations Stockton Shelly J	Jul/Aug 2016 Pg. 316-317
Dolasetron Mesylate 20-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2016 Pg. 318
Gatifloxacin 0.5% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 319
Mebendazole 100-mg Capsules Allen Loyd V Jr	Jul/Aug 2016 Pg. 320
Neomycin Sulfate 25-mg/mL Oral Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 321
Nystatin 100,000-units Vaginal Inserts Allen Loyd V Jr	Jul/Aug 2016 Pg. 322
1,2-Octanediol 5% Topical Liquid Allen Loyd V Jr	Jul/Aug 2016 Pg. 323
Phytonadione 1-mg/mL Oral Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 324
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 326
Tretinoin 10-mg Oral Capsules Allen Loyd V Jr	Jul/Aug 2016 Pg. 327
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE	Jul/Aug 2016 Pg. 328-332
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa	Jul/Aug 2016 Pg. 333-337
Stability of Ampicillin in Normal Saline and Buffered Normal Saline Maher Moureddine, Jensen Kara J, Lee David, Nix David E	Jul/Aug 2016 Pg. 338-342
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio	Jul/Aug 2016 Pg. 343-346
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M	Jul/Aug 2016 Pg. 347-350
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Allen Loyd V Jr	Sep/Oct 2016 Pg. 356
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Kochanowska-Karamyan Anna J	Sep/Oct 2016 Pg. 367-374
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Voliva John	Sep/Oct 2016 Pg. 377-378
Quality Control Analytical Methods: Method Validation Klang Mark G, Williams LaVonn A	Sep/Oct 2016 Pg. 381-386
Basics of Compounding: Clinical Pharmaceutics, Part 1 Allen Loyd V Jr	Sep/Oct 2016 Pg. 389-396
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr	Sep/Oct 2016 Pg. 399-404
Calculations Stockton Shelly J	Sep/Oct 2016 Pg. 405
Clobazam 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2016 Pg. 406
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Allen Loyd V Jr	Sep/Oct 2016 Pg. 407
Inamrinone 5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2016 Pg. 408
Levetiracetam 50-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2016 Pg. 409
Naproxen 5% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 410
Permethrin 1% Lotion Allen Loyd V Jr	Sep/Oct 2016 Pg. 411
Progesterone 10% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 412
Sodium Phosphate Oral Solution Allen Loyd V Jr	Sep/Oct 2016 Pg. 413
Tetracaine Hydrochloride 2% Topical Solution Allen Loyd V Jr	Sep/Oct 2016 Pg. 414
Tromethamine Injection Allen Loyd V Jr	Sep/Oct 2016 Pg. 415
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M	Sep/Oct 2016 Pg. 416-420
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K	Sep/Oct 2016 Pg. 421-425
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O	Sep/Oct 2016 Pg. 426-434
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael	Sep/Oct 2016 Pg. 435-437
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Tannous Elias, Tal Yana, Amarny Kamal	Sep/Oct 2016 Pg. 438-439
PreScription: Two Decades of IJPC Allen Loyd V Jr	Nov/Dec 2016 Pg. 444
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey	Nov/Dec 2016 Pg. 461-467
Why Become Pharmacy Compounding Accreditation Board Accredited? Dillon L Rad	Nov/Dec 2016 Pg. 469-474
The "Lists": What Do They Mean? Voliva John	Nov/Dec 2016 Pg. 477-479
Introduction to Quality Control in a Compounding Pharmacy Allen Loyd V Jr	Nov/Dec 2016 Pg. 481-484
Basics of Compounding: Clinical Pharmaceutics, Part 2 Allen Loyd V Jr	Nov/Dec 2016 Pg. 485-493
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Calculations Stockton Shelly J	Nov/Dec 2016 Pg. 502
Alendronate 70-mg/75-mL Drinkable Formulation Allen Loyd V Jr	Nov/Dec 2016 Pg. 504
Bosentan 6.25-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 505
Capsaicin 0.025% and Doxepin 3.3% Cream Allen Loyd V Jr	Nov/Dec 2016 Pg. 506
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Allen Loyd V Jr	Nov/Dec 2016 Pg. 507
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 508
Flumazenil 0.1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2016 Pg. 509
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 511
Melatonin 2-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Allen Loyd V Jr	Nov/Dec 2016 Pg. 513
Stability of Fentanyl Citrate in Polyolefin Bags Donnelly Ronald F	Nov/Dec 2016 Pg. 514-516
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle	Nov/Dec 2016 Pg. 517-520
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H	Nov/Dec 2016 Pg. 521-525
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Rost Erika	Nov/Dec 2016 Pg. 526-527
Return to Top